Pharma Promotion / United States / Litigation
United States ── Litigation
120 records since 1990, judged by Jev for relevance, jurisdiction, type and importance.
2026 21
- Litigation2026-09-26Lawsuit Information CenterGabapentin Dementia Lawsuit
- Litigation2026-09-21Latham & Watkins LLPDompe Settlement Highlights DOJ Continued Scrutiny of Pharmaceutical Manufacturer Donations
- Litigation2026-09-11RegtechtimesDompé u.s. agrees to pay $32m to resolve false claims act liability relating to self-disclosure of patient kickbacks — DOJ
- Litigation2026-09-10Washington TimesDompe to pay $32 million over Medicare co-pay scheme for eye drug
- Litigation2026-08-26JDSupraCooperation, Compliance, and Consequences: Inside DOJ's $46 Million Veloxis Settlement
- Litigation2026-08-11Washington TimesDrugmaker admits paying kickbacks to boost transplant drug prescriptions
- Litigation2026-08-10U.S. Department of JusticeVeloxis Pharmaceuticals Agrees to Pay $46 Million to Resolve Criminal and Civil Liability for Kickback Scheme
- Litigation2026-08-10U.S. Department of JusticeVeloxis Pharmaceuticals Agrees to Pay Over $46M to Resolve Criminal and Civil Liability for Kickback Schemes
- Litigation2026-08-03Pharmaceutical ExecutiveSandoz Agrees to $450 Million Settlement With 43 US States Over Generic Drug Antitrust Claims
- Litigation2026-07-24Fierce PharmaNovo escalates Lilly false advertising suit with planned bid to halt comparative ads
- Litigation2026-07-22NBC 4 New YorkNovo Nordisk sues rival Eli Lilly over ‘misleading' weight-loss drug advertising
- Litigation2026-07-22Medical DialoguesNovo Nordisk Files False Advertising Lawsuit Against Eli Lilly Over Zepbound Ads
- Litigation2026-07-22ChosunbizNovo Nordisk sues Eli Lilly over Mounjaro–Wegovy ad claims - CHOSUNBIZ
- Litigation2026-07-21Pharmaceutical CommerceWhy Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads
- Litigation2026-07-21The HillNovo Nordisk sues rival Eli Lilly over weight loss drug advertising
- Litigation2026-07-21Yahoo FinanceNovo Nordisk sues Eli Lilly over GLP-1 drug advertising claims
- Litigation2026-07-21Barron'sNovo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising
- Litigation2026-07-21International Business TimesNovo Nordisk Says Eli Lilly Used Misleading Weight Loss Drug Advertising. It’s Suing
- Litigation2026-07-21outlookbusiness.comNovo Nordisk Sues Eli Lilly; Alleges Misleading Weight-Loss Drug Advertising
- Litigation2026-07-20MassLive.comDrug company to pay $4.7M after admitting it paid providers to use its product
- Litigation2026-07-19MassLive.comMass. drug company settles kickback scheme lawsuit for $4.7M
2025 2
- Litigation2025-05-09U.S. Department of JusticePharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay $3.6M to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product
- Litigation2025-05-09U.S. Department of JusticePharmaceutical Manufacturer Assertio Therapeutics, Inc. to Pay $3.6 Million to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product
2024 10
- Litigation2024-12-13U.S. Department of JusticeUnited States Settles False Claims Act Allegations Against Pharmaceutical Distributor for Paying Kickbacks Through Inventory Management Systems
- Litigation2024-11-15U.S. Department of JusticePharmaceutical Company QOL Medical and CEO Agree to Pay $47M for Allegedly Paying Kickbacks to Induce Claims for QOL’s Drug Sucraid
- Litigation2024-10-10U.S. Department of JusticeTeva Pharmaceuticals Agrees to Pay $425 Million to Resolve Kickback Allegations
- Litigation2024-10-10U.S. Department of JusticeDrug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing
- Litigation2024-10-10U.S. Department of JusticeDrug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing
- Litigation2024-09-04U.S. Department of JusticePharmaceutical Company Pays $25 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
- Litigation2024-09-04U.S. Department of JusticePharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
- Litigation2024-02-22U.S. Department of JusticeFourteen Indicted in Pharmaceutical Kickback Case
- Litigation2024-02-15U.S. Department of JusticeCalifornia Pharmaceutical Company to Pay $750,000 to Resolve False Claims Act Liability for Allegedly Paying Kickbacks to Induce Prescriptions of Opioid Products
- Litigation2024-02-15U.S. Department of JusticeCalifornia Pharmaceutical Company to Pay $750,000 to Resolve False Claims Act Liability for Allegedly Paying Kickbacks to Induce Prescriptions of Opioid Products
2023 2
- Litigation2023-12-21U.S. Department of JusticePharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for Its Drug Crysvita
- Litigation2023-12-21U.S. Department of JusticePharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for its Drug Crysvita
2022 3
- Litigation2022-11-01U.S. Department of JusticeHudson Physician and Ohio Pharmaceutical Rep Plead Guilty to Roles in Prescription Drug Kickback Conspiracy
- Litigation2022-10-03U.S. Department of JusticeFlorida Medical Practice Agrees to Pay $130,000 to Resolve Allegations That it Received Kickbacks from Pharmaceutical Distributor
- Litigation2022-07-18U.S. Department of JusticeCalifornia Pain Specialist Agrees to Settle Alleged Receipt of Kickbacks from Pharmaceutical Companies Purdue Pharma and Depomed
2021 1
- Litigation2021-05-04U.S. Department of JusticePharmaceutical Manufacturer Agrees to Pay $12.6 Million to Resolve Allegations it Provided Kickbacks Through Donations to a Third-Party Charity
2020 4
- Litigation2020-08-24U.S. Department of JusticeDUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process
- Litigation2020-08-24U.S. Department of JusticeDUSA Pharmaceuticals to pay U.S. $20.75 million to settle False Claims Act allegations relating to promotion of unsupported drug administration process
- Litigation2020-08-24U.S. Department of JusticeDUSA Pharmaceuticals to pay U.S. $20.75 million to settle False Claims Act allegations relating to promotion of unsupported drug administration process
- Litigation2020-07-10U.S. Department of JusticePhysician Assistant to Pay $25,000 to Resolve Allegations of Receiving Kickbacks from Pharmaceutical Company
2019 23
- Litigation2019-12-05U.S. Department of JusticeManhattan Doctor Convicted In Manhattan Federal Court Of Accepting Bribes And Kickbacks From A Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- Litigation2019-11-20U.S. Department of JusticeThird Foundation Resolves Allegations that it Conspired with Pharmaceutical Companies to Pay Kickbacks to Medicare Patients
- Litigation2019-10-25U.S. Department of JusticeFoundations Resolve Allegations of Enabling Pharmaceutical Companies to Pay Kickbacks to Medicare Patients
- Litigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- Litigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- Litigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- Litigation2019-09-26U.S. Department of JusticePharmaceutical Company Targeting Elderly Victims Admits to Paying Kickbacks, Resolves Related False Claims Act Violations
- Litigation2019-09-11District Court, District of ColumbiaKennedy v. Novo A/S
- Litigation2019-08-16U.S. Department of JusticeFourth Manhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- Litigation2019-08-02U.S. Department of JusticeManhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- Litigation2019-06-26U.S. Department of JusticeManhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
- Litigation2019-06-25U.S. Department of JusticeNew Jersey/Pennsylvania Doctor Indicted For Accepting Bribes And Kickbacks From A Pharmaceutical Company In Exchange For Prescribing Powerful Fentanyl Drug
- Litigation2019-05-31U.S. Department of JusticeHeritage Pharmaceuticals Pays Over $7 Million to Resolve Civil False Claims Act Allegations
- Litigation2019-05-31U.S. Department of JusticePharmaceutical Company Admits to Price Fixing in Violation of Antitrust Law, Resolves Related False Claims Act Violations
- Litigation2019-05-29U.S. Department of JusticePharmaceutical Company to Pay $3.5M to Resolve Allegations of Paying Kickbacks to Doctors
- Litigation2019-04-30U.S. Department of JusticePharmaceutical Company Agrees to Pay $17.5 Million to Resolve Allegations of Kickbacks to Medicare Patients and Physicians
- Litigation2019-04-30U.S. Department of JusticePharmaceutical Company Agrees to Pay $17.5 Million to Resolve Allegations of Kickbacks to Medicare Patients and Physicians
- Litigation2019-04-25U.S. Department of JusticeTwo Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations That They Paid Kickbacks Through Copay Assistance Foundations
- Litigation2019-04-25U.S. Department of JusticeTwo Pharmaceutical Companies Agree to Pay a Total of Nearly $125 Million to Resolve Allegations that they Paid Kickbacks Through Co-Pay Assistance Foundations
- Litigation2019-04-08District Court, District of ColumbiaKennedy v. Novo A/S
- Litigation2019-04-04U.S. Department of JusticeThree Pharmaceutical Companies Agree to Pay a Total of Over $122 Million to Resolve Allegations that they Paid Kickbacks Through Co-Pay Assistance Foundations
- Litigation2019-04-04U.S. Department of JusticeThree Pharmaceutical Companies Agree to Pay a Total of Over $122 Million to Resolve Allegations That They Paid Kickbacks Through Co-Pay Assistance Foundations
- Litigation2019-02-14U.S. Department of JusticeManhattan Doctor Pleads Guilty To Accepting Bribes And Kickbacks From Pharmaceutical Company In Exchange For Prescribing Fentanyl Drug
2018 3
- Litigation2018-12-06U.S. Department of JusticeActelion Pharmaceuticals Agrees to Pay $360 Million to Resolve Allegations that it Paid Kickbacks Through a Co-Pay Assistance Foundation
- Litigation2018-10-26U.S. Department of JusticeAbbott Laboratories and AbbVie Inc. to Pay $25 Million to Resolve False Claims Act Allegations of Kickbacks and Off-Label Marketing of the Drug TriCor®
- Litigation2018-03-16U.S. Department of JusticeFive Manhattan Doctors Indicted For Accepting Bribes And Kickbacks From A Pharmaceutical Company In Exchange For Prescribing Powerful Fentanyl Narcotic
2017 2
- Litigation2017-07-24U.S. Department of JusticeCelgene Agrees to Pay $280 Million to Resolve Fraud Allegations Related to Promotion of Cancer Drugs For Uses Not Approved by FDA
- Litigation2017-02-13U.S. Department of JusticeFormer CEO of Nebraska Pharmaceutical Benefits Manager Guilty in Kickback Scheme
2016 7
- Litigation2016-12-15U.S. Department of JusticeForest Laboratories and Forest Pharmaceuticals to Pay $38 million to Resolve Kickback Allegations Under the False Claims Act
- Litigation2016-12-15U.S. Department of JusticeForest Laboratories and Forest Pharmaceuticals to Pay $38 million to Resolve Kickback Allegations Under the False Claims Act
- Litigation2016-06-09U.S. Department of JusticeManhattan U.S. Attorney Announces $54 Million Settlement Against Salix Pharmaceuticals For Using “Speaker Programs” As Mechanism To Pay Illegal Kickbacks To Doctors To Induce Them To Prescribe Salix Products
- Litigation2016-06-09U.S. Department of JusticeFormer Pharmaceutical Company Employees Arrested For Participating In Fentanyl Kickback Scheme
- Litigation2016-06-06U.S. Department of JusticePharmaceutical Companies to Pay $67 Million To Resolve False Claims Act Allegations Relating to Tarceva
- Litigation2016-06-06U.S. Department of JusticePharmaceutical Companies To Pay $67 Million To Resolve False Claims Act Allegations Relating To Tarceva
- Litigation2016-04-01Nature Reviews Drug DiscoveryAmarin agreement opens off-label promotion door
2015 5
- Litigation2015-11-20U.S. Department of JusticeManhattan U.S. Attorney Announces $370 Million Civil Fraud Settlement Against Novartis Pharmaceuticals For Kickback Scheme Involving High-Priced Prescription Drugs, Along With $20 Million Forfeiture Of Proceeds From The Scheme
- Litigation2015-06-17U.S. Department of JusticeManhattan U.S. Attorney Settles Civil Fraud Claims Against Inspire Pharmaceuticals, Inc. For Its Misleading Marketing Designed To Cause Prescriptions Of Azasite For Non-Fda Approved Uses
- Litigation2015-02-13U.S. Department of JusticeIllinois Physician Pleads Guilty to Taking Kickbacks from Pharmaceutical Company and Agrees to Pay $3.79 Million to Settle Civil False Claims Act Case
- Litigation2015-02-13U.S. Department of JusticeIllinois Physician Pleads Guilty to Taking Kickbacks from Pharmaceutical Company and Agrees to Pay $3.79 Million to Settle Civil False Claims Act Case
- Litigation2015-01-09U.S. Department of JusticePharmaceutical Manufacturer Daiichi-Sankyo to Pay $39 Million to Resolve Allegations that It Paid Kickbacks to Physicians
2014 8
- Litigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
- Litigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC To Pay $56.5 Million To Resolve False Claims Act Allegations Relating To Marketing, Promotion
- Litigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
- Litigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC To Pay $56.5 Million To Resolve False Claims Act Allegations Relating To Marketing, Promotion
- Litigation2014-09-24U.S. Department of JusticeShire Pharmaceuticals LLC to Pay $56.5 Million to Resolve False Claims Act Allegations Relating to Drug Marketing and Promotion Practices
- Litigation2014-03-26District Court, D. MassachusettsUnited States v. Pfizer, Inc.
- Litigation2014-02-21U.S. Department of JusticeEndo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses
- Litigation2014-02-21U.S. Department of JusticeEndo Pharmaceuticals And Endo Health Solutions To Pay $192.7 Million To Resolve Criminal And Civil Liability Relating To Marketing Of Prescription Drug Lidoderm For Unapproved Uses
2013 7
- Litigation2013-11-01Texas law reviewOff-Label Drug Promotion and the Use of Disclaimers*
- Litigation2013-07-30U.S. Department of JusticeWyeth Pharmaceuticals Agrees to Pay $490.9 Million for Marketing the Prescription Drug Rapamune for Unapproved Uses
- Litigation2013-07-30U.S. Department of JusticeWyeth Pharmaceuticals Agrees To Pay $490.9 Million For Marketing The Prescription Drug Rapamune For Unapproved Uses
- Litigation2013-07-18U.S. Department of JusticePharmaceutical Company Agrees To Pay $3.5 Million To Settle False Claims Act Allegations
- Litigation2013-05-24U.S. Department of JusticeISTA Pharmaceuticals, Inc. Plead Guilty to Federal Felony Charges; Will Pay $33.5 Million to Resolve Criminal lLability and False Claims Act Allegations
- Litigation2013-03-05U.S. Department of JusticePar Pharmaceuticals Pleads Guilty and Agrees to Pay $45 Million to Resolve Civil and Criminal Allegations Related to Off-Label Marketing
- Litigation2013-03-05U.S. Department of JusticePar Pharmaceuticals Pleads Guilty and Agrees to Pay $45 Million to Resolve Civil and Criminal Allegations Related to Off-Label Marketing
2012 4
- Litigation2012-12-27U.S. Department of JusticeVictory Pharma Inc. of San Diego Pays $11.4 Million to Resolve Kickback Allegations in Connection with Promotion of Its Drugs
- Litigation2012-12-12U.S. Department of JusticePfizer Agrees to Pay $55 Million for IllegallyPromoting Protonix for Off-Label Use
- Litigation2012-05-07U.S. Department of JusticeAbbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote
- Litigation2012-03-28U.S. Department of JusticeMississippi Pharmaceutical Firm and CEO to Pay $2.8 Million to Resolve Allegations of Illegal Marketing of Unapproved Drugs
2011 5
- Litigation2011-08-10District Court, D. New JerseyIn Re Neurontin Antitrust Litigation
- Litigation2011-06-09U.S. Department of JusticeU.S. Subsidiary of Belgian Pharmaceutical Manufacturer Pleads Guilty to Off-Label Promotion; Company to Pay More Than $34 Million
- Litigation2011-05-04U.S. Department of JusticePharmaceutical Giant, Serono, Agrees to Pay $44.3 Million to Settle False Claims Act Case
- Litigation2011-04-05PLoS MedicineStrategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
- Litigation2011-01-01Digital Access to Scholarship at Harvard (DASH) (Harvard University)Pharma Fights Back: Combating Heightened Prosecution of Off-Label Promotion with Claims of First Amendment Violations
2010 8
- Litigation2010-12-07U.S. Department of JusticeKos Pharmaceuticals to Pay More Than $41 Million to Resolve Kickback and Off-Label Promotion Allegations
- Litigation2010-12-07U.S. Department of JusticeKos Pharmaceuticals to Pay More Than $41 Million to Resolve Kickback and Off-Label Promotion Allegations
- Litigation2010-09-30U.S. Department of JusticeNovartis Pharmaceuticals Corp. to Pay More Than $420 Million to Resolve Off-label Promotion and Kickback Allegations
- Litigation2010-09-01U.S. Department of JusticeAllergan Agrees to Plead Guilty and Pay $600 Million to Resolve Allegations of Off-Label Promotion of Botox®
- Litigation2010-04-29U.S. Department of JusticeTwo Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
- Litigation2010-04-27U.S. Department of JusticePharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing
- Litigation2010-04-27U.S. Department of JusticePharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing
- Litigation2010-03-16U.S. Department of JusticeAlpharma to Pay $42.5 Million to Resolve False Claims Act Allegations in Connection with Promotion of Drug Kadian
2009 3
- Litigation2009-11-09Psychology todayDrug Makers Still Repeatedly Breaking the Law over 'Off-Label' Promotion
- Litigation2009-05-13District Court, D. MassachusettsIn re Neurontin Marketing, Sales Practices & Products Liability Litigation
- Litigation2009-01-15U.S. Department of JusticeEli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa
2008 1
- Litigation2008-05-29BMJMerck to pay $58m in settlement over rofecoxib advertising
2004 1
- Litigation2004-01-01Digital Access to Scholarship at Harvard (DASH) (Harvard University)A Case at a Crossroad: United States ex rel. Franklin v. Parke-Davis and the Intersection of Regulating Promotion of Off-Label Uses and Medicaid Fraud and Abuse